Last updated: 2026-10-12 22:37:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Boston Scientific Corp. (BSX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $43,86, with a market capitalization of $61,93B and a P/E ratio of 16,85. Over the past 52 weeks, its price has ranged from $41,39 to $105,65. This page covers its latest market performance, valuation, price trends and company information.
$61,93B | |
$43,10 | |
$109,50 | |
$4,79 | |
$42,73 | |
11,25M | |
20,00M | |
16,85 | |
$105,65 | |
$41,39 | |
-- | |
-- |
Boston Scientific Corp. (BSX) is trading at $43,73 in after-hours trading as of 2026-10-12 22:33:00, up 2,34% ($1,00) from the regular-session close of $42,73.
After-hours trading shows how investors are pricing BSX after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Boston Scientific Corp. (BSX) moved from $43,23 to $43,86, representing a gain of 1,45% ($0,63).
The stock traded between $41,39 and $43,96 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 16,34 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 3,8%
BSX is currently trading at $43,86, placing it 3,8% of the way from its 52-week low of $41,39 to its 52-week high of $105,65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 59000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Boston Scientific Corp. (BSX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.